EIF4E promotes gefitinib resistance in non-small cell lung cancer by activating the Wnt/β-catenin pathway
Bo Zhang(Wenzhou Medical University), Lilong Xia(Zhejiang Hospital)
Cited by 0
Related Papers
Identification of FOXM1 as a specific marker for triple‑negative breast cancer
|International Journal of Oncology|2018|64